Significance and management of micrometastases in patients with breast cancer.
The routine use of sentinel lymph node biopsy in the care of patients with invasive breast cancer has led to an increase in the identification of micrometastases in the axillary lymph nodes. Currently, the clinical relevance of this small-volume disease is debated. This article reviews the most current literature with respect to detection of micrometastases and isolated tumor cells in sentinel lymph nodes, the prognostic significance of these findings, and recommendations for locoregional and systemic treatment.
Mittendorf
Elizabeth A
EA
The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, 1515 Holcombe Blvd, Unit 444, Houston, TX 77030, USA. eamitten@mdanderson.org
Hunt
Kelly K
KK
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D019468:Disease Management; D018450:Disease Progression; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis / Q000175:diagnosis / Q000473:pathology* / Q000532:radiotherapy; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D009367:Neoplasm Staging; D015588:Observer Variation; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D021701:Sentinel Lymph Node Biopsy